Segment Information (Tables)

6 Months Ended

Jun. 30, 2023

Segment Reporting [Abstract]

Summary of Information by Reportable Segments

The following table presents information about the Company’s reportable segments for the three and six months ended June 30, 2023 and 2022 (in thousands):

	Three Months Ended June 30,
	2023									2022
	Sorrento Therapeutics			Scilex			Total			Sorrento Therapeutics			Scilex			Total
External revenues	$	2,443		$	12,582		$	15,025		$	3,535		$	7,926		$	11,461
Operating expenses		56,861			35,397			92,258			109,709			20,113			129,822
Operating loss		(54,418	)		(22,815	)		(77,233	)		(106,174	)		(12,187	)		(118,361	)
Unrestricted cash		34,572			35,177			69,749			63,470			6,875			70,345

	Six Months Ended June 30,
	2023									2022
(in thousands)	Sorrento Therapeutics			Scilex			Total			Sorrento Therapeutics			Scilex			Total
External revenues	$	8,112		$	23,164		$	31,276		$	15,107		$	14,738		$	29,845
Operating expenses		144,796			70,055			214,851			219,359			35,730			255,089
Operating loss		(136,684	)		(46,891	)		(183,575	)		(204,252	)		(20,992	)		(225,244	)
Unrestricted cash		34,572			35,177			69,749			63,470			6,875			70,345